Roivant Sciences Ltd.

Ownership Transactions Reported by 23 Insiders

Symbol
ROIV on Nasdaq
Industry
Pharmaceutical Preparations
Location
Clarendon House, 2 Church Street, Hamilton Hm11, Bermuda

Insiders trading volume in the past year

Roivant Sciences Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dexcel Pharma Technologies Ltd. 10%+ Owner $1.06B Nov 10, 2022
QVT Financial LP Director by Deputization $778M -$10.9M -1.39% Sep 25, 2024
SVF Investments (UK) Ltd 10%+ Owner $756M Sep 28, 2023
Sumitomo Chemical Co., Ltd. 10%+ Owner $737M Jun 22, 2023
Vivek Ramaswamy 10%+ Owner $696M -$33.2M -4.54% Apr 2, 2024
Daniel Allen Gold Director $338M -$51.8M -13.3% Sep 24, 2024
Mayukh Sukhatme Pres&Chief Investment Officer, Director $261M Jul 26, 2024
Matthew Gline CEO, Director $199M -$23.4M -10.5% Nov 20, 2024
Viking Global Investors Lp 10%+ Owner $133M Jun 22, 2023
Viking Global Performance Llc 10%+ Owner $133M Jun 22, 2023
Keith Manchester Director $15M -$5.87M -28.1% Sep 24, 2024
Benjamin Zimmer President, Roivant Health $12.1M Oct 1, 2021
Eric Venker President & COO $6.87M -$3.36M -32.8% Nov 20, 2024
Richard Pulik Cfo $3.51M Nov 28, 2024
Rakhi Kumar Chief Accounting Officer $3.39M -$2.97M -46.8% Nov 20, 2024
Ilan Oren Director $1.14M Oct 21, 2024
James C. Momtazee Director $1.09M Oct 21, 2024
Andrew Lo Director $540K Sep 15, 2022
Melissa Epperly Director $443K Oct 21, 2024
Meghan Fitzgerald Director $356K Sep 12, 2024
Masayo Tada Director Oct 1, 2021
Patrick Machado Director Oct 1, 2021
Hiroshi Nomura Director Sep 16, 2022

Recent Insider Transactions by Companies or Individuals for Roivant Sciences Ltd.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.